Improved method for the simultaneous determination of proguanil and its metabolites by high-performance liquid chromatography and solid-phase extraction of 100-μl capillary blood samples dried on sampling paper

This publication has 15 references indexed in Scilit:

• High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu
  The Lancet, 1997
• Geographical/Interracial Differences in Polymorphic Drug Oxidation
  Clinical Pharmacokinetics, 1995
• Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe*
  Clinical Pharmacology & Therapeutics, 1995
• The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
  British Journal of Clinical Pharmacology, 1990
• High-performance liquid chromatographic determination of quinine in plasma, whole blood and samples dried on filter paper
  Journal of Chromatography B: Biomedical Sciences and Applications, 1990
• Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
  British Journal of Clinical Pharmacology, 1989
• Detection and determination of antimalarial drugs and their metabolites in body fluids
  Journal of Chromatography B: Biomedical Sciences and Applications, 1988
• Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations
  Clinical Pharmacology & Therapeutics, 1985
• The activity of proguanil and its metabolites, cycloguanil andp-chlorophenylbiguanide, againstPlasmodium falciparum in vitro
  Pathogens and Global Health, 1984
• A Metabolite of ‘Paludrine’ with High Antimalarial Activity
  Nature, 1951